67-5

83/110

Murata A, Shimizu M, Shitara J, Kato T, Hiki M, Sai E, Miyauchi K, Daida H: Prevalence and Significance of Restless Legs Syndrome in Patients With Coronary Artery Disease.Am J Cardiol. 2019 May 15; 123: 1580-1586. 13) Endo H, Dohi T, Miyauchi K, Kuramitsu S, Kato Y, Okai I, Yokoyama M, Yokoyama T, Ando K, Okazaki S, Shimada K, Suwa S, Daida H: Clinical significance of non-culprit plaque regression following acute coronary syndrome: A serial intravascular ultrasound study. J Cardiol. 2019 Aug; 74: 102-108. 14) Wada H, Miyauchi K, Daida H: J Cardiol. 2019 Aug; 74: 102-108. Expert Rev Cardiovasc Ther. 2019 Feb; 17: 127-133. 15) Endo H, Dohi T, Funamizu T, Shitara J, Wada H, Doi S, Naito R, Konishi H, Ogita M, Iwata H, Kasai T, Okazaki S, Isoda K, Shimada K, Miyauchi K, Daida H: Long-Term Predictive Value of High-Sensitivity C-Reactive Protein for Cancer Mortality in Patients Undergoing Percutaneous Coronary Intervention. Circ J. 2019 Feb 25; 83: 630-636. 16) Wada H, Dohi T, Miyauchi K, Daida H: Reply to: “Comment on “Mean platelet volume and long-term cardiovascular outcomes in patients with stable coronary artery disease””. Athero-sclerosis. 2019 Jan; 280: 195-196. 17) Dohi T, Kasai T, Endo H, Wada H, Yanagi-sawa N, Nojiri S, Funamizu T, Shitara J, Doi S, Kato Y, Okai I, Iwata H, Isoda K, Okazaki S, Miyauchi K, Daida H: CPAP effects on atherosclerotic plaques in patients with sleep- disordered breathing and coronary artery disease: The ENTERPRISE trial. J Cardiol. 2019 Jan; 73: 89-93. 18) Shitara J, Ogita M, Wada H, Tsuboi S, Endo H, Doi S, Konishi H, Naito R, Dohi T, Kasai T, Okazaki S, Isoda K, Suwa S, Miyauchi K, Daida H: Clinical impact of high-sensitivity C-reactive protein during follow-up on long-term adverse clinical outcomes in patients with coronary artery disease treated with percutaneous coronary intervention. J Cardiol. 2019 Jan; 73: 45-50. 19) Yasuda S, Kaikita K, Akao M, Ako J, Matoba T, Nakamura M, Miyauchi K, Hagiwara N, Kimura K, Hirayama A, Matsui K, Ogawa H: AFIRE Investigators. Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease. N Engl J Med. 2019 Sep 19; 381: 1103-1113. 20) Ako J, Hibi K, Tsujita K, Hiro T, Morino Y, Kozuma K, Shinke T, Otake H, Uno K, Louie MJ, Takagi Y, Miyauchi K: Effect of Aliro-cumab on Coronary Atheroma Volume in Japanese Patients With Acute Coronary Syndrome - The ODYSSEY J-IVUS Trial.Circ J. 2019 Sep 25; 83: 2025-2033. 21) Kimura K, Kimura T, Ishihara M, Nakagawa Y, Nakao K, Miyauchi K, Sakamoto T, Tsujita K, Hagiwara N, Miyazaki S, Ako J, Arai H, Ishii H, Origuchi H, Shimizu W, Takemura H, Tahara Y, Morino Y, Iino K, Itoh T, Iwanaga Y, Uchida K, Endo H, Kongoji K, Sakamoto K, Shiomi H, Shimohama T, Suzuki A, Taka-hashi J, Takeuchi I, Tanaka A, Tamura T, Nakashima T, Noguchi T, Fukamachi D, Mizuno T, Yamaguchi J, Yodogawa K, Kosuge M, Kohsaka S, Yoshino H, Yasuda S, Shimokawa H, Hirayama A, Akasaka T, Haze K, Ogawa H, Tsutsui H, Yamazaki T: Japanese Circula-tion Society Joint Working Group. JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome.Circ J. 2019 Apr 25; 83: 1085-1196. 22) Matsumura-Nakano Y, Shizuta S, Komasa A, Morimoto T, Masuda H, Shiomi H, Goto K, Nakai K, Ogawa H, Kobori A, Kono Y, Kaitani K, Suwa S, Aoyama T, Takahashi M, Sasaki Y, Onishi Y, Mano T, Matsuda M, Motooka M, Tomita H, Inoko M, Wakeyama T, Hagi-wara N, Tanabe K, Akao M, Miyauchi K, Yajima J, Hanaoka K, Morino Y, Ando K, Furukawa Y, Nakagawa Y, Nakao K, Kozuma K, Kadota K, Kimura K, Kawai K, Ueno T, Okumura K, Kimura T: OAC-ALONE Study Investigators.Open-Label Randomized Trial Comparing Oral Anticoagulation With and Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease Beyond 1 Year After Coronary Stent Implantation. Circulation. 2019 Jan 29; 139: 604-616. 23) Kurokawa K, Sai E, Hayashi E, Minowa K, Sugano K, Yoshihara T, Miyazaki T, Hiki M, Yokoyama T, Suzuki M, Miyauchi K: Useful-ness of Cardiac Magnetic Resonance in the 487